Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Sarcoma, Kaposi

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Sarcoma, Kaposi in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aime, S; Alberti, D; Bussolati, B; Camussi, G; Esposito, G; Geninatti-Crich, S; Grange, C; Tei, L1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Sarcoma, Kaposi

ArticleYear
Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.
    Cancer research, 2010, Mar-15, Volume: 70, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Contrast Media; Doxorubicin; Heterocyclic Compounds; Humans; Liposomes; Magnetic Resonance Imaging; Male; Mice; Mice, SCID; Neural Cell Adhesion Molecules; Organometallic Compounds; Polyethylene Glycols; Sarcoma, Kaposi

2010